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INTRODUCTION
Surgical resection is the treatment of choice for patients
with thyroid cancer; however, the optimal extent of thyroid
resection and lymph node dissection remain controversial.
Based on the extent of disease, total thyroidectomy or less-
than-total thyroidectomy is chosen. Central compartment
node dissection (CCND) is usually performed with thyroidec-
tomy for prophylactic purposes, whereas lateral neck dissec-
tion is performed only in patients in whom metastasis is clin-
ically evident. In cases of follicular cancer, a hemithyroidec-
tomy is usually performed for minimally invasive cancers,
and a total thyroidectomy for widely invasive cancers, although
the optimal approach for these cancers remains controversial.
In patients with medullary cancer, total thyroidectomy with
compartment-oriented node dissection is usually considered
adequate (1).
Although the benefits of extended resection are an increased
survival rate and a decreased recurrence rate, all surgical pro-
cedures have the potential to cause complications, and more
extensive resections may be associated with substantially in-
creased complication rates (2, 3).
We therefore investigated surgical complications after thy-
roid cancer surgery and the association between the extent
of surgery and complication rates.
MATERIALS AND METHODS
Approval to conduct a retrospective review of the images
and medical records of patients was obtained from the Insti-
tutional Review Board of Yonsei University College of Medi-
cine. Medical records of 3,137 patients who underwent thy-
roid surgery at the Thyroid Cancer Clinic, Department of
Surgery, Yonsei University College of Medicine between Jan-
uary 2006 and December 2007 were retrospectively reviewed. 
Patients who had a recurrent or persistent thyroid cancer
and who underwent thyroid surgery for benign thyroid dis-
ease were excluded, and 2,636 (84.0%) patients were enrolled
in the present study. Of the 2,636 patients, 2,596 (98.5%) had
papillary cancers, 22 (0.8%) follicular cancers, and 18 (0.7%)
medullary cancers. Patients could be divided into four groups
according to the extent of surgery; less-than-total thyroidecto-
my with central compartment node dissection (CCND) (Group
541
Yong Sang Lee, Kee-Hyun Nam, 
Woong Youn Chung, Hang-Seok Chang,
and Cheong Soo Park
Thyroid Cancer Center, Department of Surgery, 
Yonsei University College of Medicine, Seoul, Korea
Address for Correspondence
Hang-Seok Chang, M.D.
Thyroid Cancer Center, Department of Surgery, 
Gangnam Severance Hospital, Yonsei University 
College of Medicine, 712 Eonju-ro, Gangnam-gu,
Seoul 135-720, Korea
Tel : +82.2-2019-3370, Fax : +82.2-3462-5994
E-mail : surghsc@yuhs.ac
J Korean Med Sci 2010; 25: 541-5 ISSN 1011-8934
DOI: 10.3346/jkms.2010.25.4.541
Postoperative Complications of Thyroid Cancer in a Single Center
Experience
The aim of this study was to investigate the complications following surgical treat-
ment of thyroid cancer and the association between the extent of surgery and com-
plication rates. A total of 2,636 patients who underwent surgery due to thyroid can-
cer were retrospectively reviewed to identify surgical complications. Complication
rates were assessed according to the extent of surgery, which was classified as fol-
lows; less-than-total thyroidectomy with central compartment node dissection (CCND)
(Group I, n=636), total thyroidectomy with CCND (Group II, n=1,390), total thyroidec-
tomy plus ipsilateral neck dissection (Group III, n=513), and total thyroidectomy plus
bilateral neck dissection (Group IV, n=97). The most common surgical complica-
tion was symptomatic hypoparathyroidism, of which 28.4% of cases were transient
and 0.3% permanent. The other surgical complications included vocal cord palsy
(0.7% transient, and 0.2% permanent), hematoma (0.5%), seroma (4.7%), chyle
fistula (1.8%), and Horner’s syndrome (0.2%). The complication rates increased
significantly with increasing the extent of surgery from Group I to Group IV. The
more extensive surgery makes more complications, such as hypoparathyroidism,
seroma, and others.
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1390); total thyroidectomy plus ipsilateral neck dissection
(Group III, n=513) and total thyroidectomy plus bilateral
neck dissection (Group IV, n=97). 
The extent of surgery was determined according to the Ame-
rican Thyroid Association (ATA) guidelines (4). A total thy-
roidectomy was performed if any of the following criteria were
met: age <15 yr or >45 yr, a history of radiation exposure in
the head and neck, known distant metastases, contralateral
thyroid nodules, extrathyroidal extension, cervical lymph node
involvement, and a first-degree family history of thyroid car-
cinoma. A less-than-total thyroidectomy was selected for pa-
tients with small, isolated, intrathyroidal carcinomas with-
out gross nodal involvement. Central compartment clearance
was performed routinely for prophylactic purposes, whereas
lateral neck dissection was performed only in patients with
clinically positive lateral neck nodes.
All patients underwent preoperative examination of vocal
cord movement by direct laryngoscopy and routine preoper-
ative measurements of serum calcium, phosphorus, and para-
thyroid hormone levels. During surgery, all parathyroid glands
were identified and preserved as much as possible. Postoper-
ative laryngoscopy was performed only in patients who expe-
rienced symptomatic voice changes after surgery.
Postoperative complications including hypoparathyroidism,
recurrent laryngeal nerve (RLN) injury or palsy, hematoma,
seroma, chyle fistula, and Horner’s syndrome were assessed
based on clinical findings. Hypoparathyroidism was consid-
ered permanent when calcium and vitamin D therapy was
required more than 6 months after surgery. Regarding RLN
palsy, permanent palsy included direct injury to the nerve and
cord palsy more than 6 months. 
The surgical complications and complication rates were
assessed for each of the four patient groups and comparisons
among groups were made using Fisher’s exact test; when nec-
essary, data were transformed to obtain results distributed with
equal variance. Pearson’s chi-square test was used to assess the
relationship between each group and the following potential
predictors of surgical complications: age, sex, tumor size, nodal
status, extracapsular invasion, underlying thyroiditis, mul-
tiplicity, hospital stay and postoperative complications. Sta-
tistical significance was defined as a P value <0.05.
RESULTS
Demographic and clinicopathologic characteristics of the
total patient population and of the four patient groups are list-
ed in Table 1. The proportion of male patients, mean tumor
diameter, number of dissected and metastatic lymph nodes,
and mean hospital stay increased significantly with increasing
extent of surgery (P<0.001). However, mean age at diagnosis
had no differences between each group (P<0.001) (Table 1). 
Assessment of complications showed that symptomatic
hypoparathyroidism occurred in 757 patients (28.7%), of
whom 749 (28.4%) cases were transient and 8 (0.3%) were
permanent hypoparathyroidism. And the incidence rates in-
creased with increasing extent of surgery (Table 2). The inci-
dence of incidentally removed parathyroids during surgery
was not different between groups (P=0.002). However, the
incidence of parathyroid autotransplantation increased sig-
nificantly with increasing the extent of surgery (Table 3).
The incidence of RLN palsy, which was 0.8% in all pati-
ents, was also significantly related to the extent of surgery,
with incidences of 0.5%, 0.6%, 1.2%, and 3.1% in Groups
I, II, III, and IV, respectively (P=0.026). By contrast, the in-
cidence of hematoma, which was 0.5% overall, was not asso-
ciated with the extent of surgery (P=0.744).
The incidence rates of other complications were also sig-
nificantly associated with the extent of surgery. For example,
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Group I, less-than-total thyroidectomy with central compartment node dissection; Group II, total thyroidectomy with central compartment node dissec-













Age (mean, yr) 46.8±11.6 44.0±10.9 48.3±11.1 46.4±12.8 45.1±14.0 <0.001
Male:female 360:2276 (1:6.3) 68:568 (1:8.4) 172:1228 (1:7.1) 95:418 (1:4.4) 25:72 (1:2.9) <0.001
Tumor size (mean, cm) 1.02±0.77 0.66±0.51 0.99±0.65 1.43±0.97 1.70±1.12 <0.001
Capsular invasion 53.5% 30.4% 55.9% 72.3% 72.2% <0.001
Multiplicity <0.001
Unilateral 10.5% 11.4% 10.6% 9.0% 10.4%
Bilateral 23.9% 2.8% 29.3% 30.5% 50.0%
Underlying thyroiditis 5.2% 5.9% 5.2% 3.6% 9.7% 0.080
Nodal status (mean)
Dissected lymph nodes 11.3±15.1 5.2±4.6 5.3±4.1 25.2±18.1 48.1±22.0 <0.001
Metastatic lymph nodes 2.1±4.6 0.4±1.0 0.9±1.7 5.0±6.4 11.1±10.5 <0.001
Hospital stay (mean, days) 5.6±2.7 4.8±1.9 5.3±2.2 6.9±3.2 9.0±4.6 <0.001
Table 1. Demographic and clinicopathologic characteristics of patients seroma, which was reported in 4.7% of all patients, was 3.9%,
3.7%, 7.7%, and 8.3% of patients in Groups I, II, III, and
IV, respectively (P=0.002). Chyle fistula, which had an over-
all incidence of 1.8%, was reported in 0.5%, 0.8%, 5.1%,
and 6.2% of patients in Groups I, II, III, and IV, respective-
ly (P<0.001); and Horner’s syndrome, which had an overall
incidence of 0.2%, was reported in 0%, 0%, 0.8%, and 1.0%
of patients in Groups I, II, III, and IV, respectively (P=0.001)
(Table 2).
DISCUSSION
Postoperative complications following thyroid surgery can
include transient and permanent hypoparathyroidism, RLN
injury or palsy, hematoma, seroma, chyle fistula, Horner’s syn-
drome, and injury to some motor nerves in the neck. The inci-
dence of transient hypoparathyroidism has been reported to
range from 0.3% to 49%, and that of permanent hypopara-
thyroidism from 0% to 13% (5, 6). In addition, the incidence
of RLN palsy has been found to range from 0% to 5% (5-7),
and those of hematoma, seroma, chyle fistula, and Horner’s
syndrome from 0% to 3%, 0% to 6%, 1.0% to 2.5% and
1.8% to 7.8%, respectively (6, 8, 9). In our institution, we
found that the incidence rates of transient hypoparathyroidism,
permanent hypoparathyroidism, transient RLN palsy, perma-
nent RLN palsy, hematoma, seroma, chyle fistula, and Hor-
ner’s syndrome were 28.4%, 0.3%, 0.7%, 0.2%, 0.5%, 4.7%,
1.8%, and 0.2%, respectively all of which are in good agree-
ment with previous reports (5-9).
Hypoparathyroidism is the most common complication
after total or near-total thyroidectomy due to the unintention-
al removal of parathyroid glands or poor blood flow to the
glands. Patients with permanent hypoparathyroidism require
life-long treatment with calcium and vitamin D, so this com-
plication is considered serious. Transient hypoparathyroidism,
however, rarely affects quality of life. 
Studies that have performed multivariate analysis on factors
predictive of postoperative hypoparathyroidism have shown
differences in terms of the effects of surgical extent, surgeon’s
experience, and method of study (10-12). In our series, the
incidence rates of transient and permanent hypoparathyroidism
increased significantly with increasing extent of surgery. The
incidence of incidental parathyroid removal during surgery
showed no differences between groups, which indicated that
the incidental removal of parathyroid glands did not affect
the incidence of hypoparathyroidism. On the contrary, the
incidence of parathyroid autotransplantation during surgery
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Group I, less-than-total thyroidectomy with central compartment node dissection; Group II, total thyroidectomy with central compartment node dissec-















Transient 28.4% 6.6% 30.7% 44.4% 53.6%
Permanent 0.3% 0% 0.3% 0.6% 1.0%
RLN palsy 0.026
Transient 0.7% 0.5% 0.4% 1.0% 3.1%
Permanent 0.2% - 0.2% 0.2%
Hematoma 0.5% 0.3% 0.4% 0.6% 1.0% 0.744
Seroma 4.7% 3.9% 3.7% 7.7% 8.3% 0.002
Chyle fistula 1.8% 0.5% 0.8% 5.1% 6.2% <0.001
Horner’s syndrome 0.2% --0.8% 1.0% 0.001
Table 2. Complication rates according to the extent of thyroid surgery
Group I, less-than-total thyroidectomy with central compartment node dissection; Group II, total thyroidectomy with central compartment node dis-












Parathyroid removal 379 (14.4%) 95 (14.9%) 194 (14.0%) 76 (14.8%) 14 (14.4) 0.002
One 334 (88.1%) 79 (83.2%) 173 (89.2%) 69 (90.8%) 13 (92.9%)
Two 42 (11.1%) 14 (14.7%) 20 (10.3%) 7 (9.2%) 1 (7.1%)
Three 3 (0.8%) 2 (2.1%) 1 (0.5%) 0 (0%) 0 (0%)
Autotransplantation 17 (0.6%) 2 (0.3%) 8 (0.6%) 5 (1.0%) 2 (2.1%) 0.037
Table 3. Parathyroid glands removed by surgeryincreased significantly with increasing the extent of surgery.
This result revealed that more extended surgery caused more
ischemic changes to parathyroids. Thus, hypoparathyroidism
following thyroid surgery is likely to be due to the decrease
of blood flow to the parathyroid glands with increasing extent
of surgery.
Similar to permanent hypoparathyroidism, RLN palsy also
has marked effects on patient quality of life. The causes of
transient RLN palsy include excessive nerve skeletonization,
neuritis caused by scar tissue and myelinic lesion, axon dam-
age caused by excessive strain, ‘‘a frigore’’ or ‘‘a calore’’ paral-
ysis, thermic lesions caused by electrocoagulation, viral neu-
ritis, and difficult endotracheal intubation (13). Patients with
vocal cord palsy should start logopedic rehabilitation as early
as possible. The injured RLNs are usually treated by voice
therapy, laryngeal reinnervation procedures, injection laryn-
goplasty with materials such as gelfoam, fat and collagen, ary-
tenoid adduction, or medialization laryngoplasty with ex-
panded polytetrafluoroethylene (EPTTE, Gore-Tex) (14-16).
Although intraoperative RLN monitoring using an electrode
inserted into the endotracheal tube has been suggested, it does
not seem to decrease the incidence of RLN palsy (17, 18). In
our series, the rate of transient RLN palsy increased signifi-
cantly with increasing extent of surgery, whereas permanent
RLN palsy was not related to the extent of surgery; this is
likely that permanent palsy was caused by invasion of the
RLN nerve or accidental injuries.
Hematoma after thyroidectomy is a potentially fatal com-
plication. Acute respiratory embarrassment due to hemato-
ma formation is lethal unless the hematoma is immediately
removed surgically. Meticulous hemostasis is therefore manda-
tory in thyroid surgery, and the level of care taken during the
surgery cannot be compromised (19). Seroma may require
aspiration to make the patients comfortable; aspiration can
be easily performed by inserting a needle above the incision
when fluid collection is noted (19). In our series, 0.5% of the
patients experienced postoperative hematoma and 4.7% of
the patients experienced seroma. The incidences of these com-
plications also increased with increasing extent of surgery.
Chyle fistula is a rare and troublesome complication. If un-
treated, it can cause severe disturbances in fluid and electrolyte
balance, protein loss, delayed wound healing, abnormal meta-
bolic status, shock, and even death (8). The most common
cause of chyle fistula is thoracic duct injury, mainly on the
left side (responsible for 75-92% of cases) (20). Most chyle
fistulas (75%) are detected during surgery, or detected after
surgery (21, 22). Chyle fistula is usually found upon post-
operative commencement of an oral diet and is indicated by
milky drainage, a sudden increase in drainage volume, bulg-
ing supraclavicular fossa, and induration or erythema of the
skin (22, 23). Low output fistulas (<500 mL/day) can usually
be conservatively managed by fasting or maintenance of a low-
fat diet, a semi-Fowler’s position, a diet of medium-chain fatty
acids, total parenteral nutrition, compression dressing on the
supraclavicular fossa, and the use of somatostatin analogues
(such as octreotide) (24, 25). High output fistulas (>500 mL/
day), however, require surgical intervention for direct closure
of the fistula or thoracic duct ligation (26, 27). 
Horner’s syndrome is usually associated with unique clin-
ical features based on the anatomical location of the underly-
ing pathologic process. Classical symptoms include miosis,
ptosis, anhydrosis, and in some cases, nasal stuffiness. Horner’s
syndrome results from paralysis of the ipsilateral sympathetic
chain due to extensive surgical dissection around the sympa-
thetic trunk lying along the deep posterior and medial to the
carotid artery, between the prevertebral fascia and the carotid
sheath (9, 28). There is no specific treatment for Horner’s syn-
drome; however, postoperative ophthalmic problems can be
managed by ophthalmic supportive care, ptosis can be treated
with blephaloplasty or administration of a2-adrenaline recep-
tor agonists, and nasal stuffiness can be treated with turbinec-
tomy. Careful dissection around the prevertebral fascia and
the carotid sheath is necessary to avoid injury to the sympa-
thetic chains when performing a radical neck dissection. In
our series, the Horner’s syndrome only occurred in patients
the lateral neck dissection groups. Rare complications such
as injury to the spinal accessory nerve, hypoglossal nerve, vagus
nerve, and phrenic nerve were not seen in our patients.
The dilemma associated with the surgical principles of thy-
roid cancer surgery includes achieving the proper oncologic
outcomes while reducing postoperative complications. Alth-
ough extended resection increases survival rate and decreases
the recurrence rate, all surgical procedures have the potential
to cause complications and more extensive resections may be
associated with substantially increased complication rates.
In conclusion, the results of our study suggest that most
thyroid cancer surgeries are safe and can be performed with
minimal morbidity, but an increased risk of surgical compli-
cations, particularly hypoparathyroidism, is still a problem
that needs be solved in patients who require more extensive
surgery. Therefore, an understanding of the relationship bet-
ween complication patterns and the extent of surgery seems
to be crucial for thyroid cancer surgery.
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